Kcne3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
KCNE3 modulates potassium channel function. It forms complexes with KCNQ1 and other channels to create diverse channel properties.
KCNE3 Protein is encoded by the KCNE3 gene. It is a KCNE family potassium channel regulatory subunit. The UniProt ID is Q9NP86.
- Molecular Weight: 17 kDa
- Localization: Plasma membrane
- PDB Structures: None determined
KCNE3 modulates potassium channel function. It forms complexes with KCNQ1 and other channels to create diverse channel properties.
The protein is expressed in Plasma membrane and plays important roles in cellular physiology.
KCNE3 mutations are associated with cardiac arrhythmias including Brugada syndrome.
KCNE3 modulators are under investigation.
The study of Kcne3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Potassium channels in neurons: Hille B. Ionic Channels of Excitable Membranes. 3rd ed. Sinauer Associates; 2001.
- KCNN channels (SK/IK): Stocker M. Nat Rev Neurosci. 2004;5(10):758-770. PMID:15378036
- KCa channels in neurodegeneration: Shah NH, et al. Nat Rev Neurosci. 2018;19(9):485-498. PMID:30046008
- Potassium channel dysfunction in AD: Angulo E, et al. J Neurosci. 2004;24(20):4676-4682. PMID:15140932
- Potassium channels and neuronal excitability: Bean BP. Nat Rev Neurosci. 2007;8(6):451-465. PMID:17541432
- SK channel activators as therapy: Ehling P, et al. Nat Rev Drug Discov. 2020;19(11):773-789. PMID:32877965
- Potassium channels in PD: Lüscher C, Slesinger PA. Nat Rev Neurosci. 2010;11(9):569-579. PMID:20649637
- Ion channel therapeutics: Garnock-Jones KP. CNS Drugs. 2017;31(5):383-392. PMID:28447065
- Stocker M. Calcium-activated potassium channels: molecular diversity and function. Physiological Reviews. 2004;84(3):903-934. PMID:15269336
- Kohler M, Hirschberg B, Bond CT, et al. Small-conductance, calcium-activated potassium channels from mammalian brain. Science. 1996;273(5282):1709-1714. PMID:8781166
- Wulff H, Kolski-Andreaco A. Modulators of small- and intermediate-conductance Ca2+-activated K+ channels. Current Pharmaceutical Design. 2007;13(31):3179-3184. PMID:17979758
- Dessauer CW, Sorscher EJ, Brennan TJ, et al. Isolation and characterization of a novel large conductance calcium-activated potassium channel. Journal of Biological Chemistry. 1998;273(50):33123-33129. PMID:9837872
- Bhattacharjee A, Gan L, Kaczmarek LK. Localization of the Slack potassium channel in the rat central nervous system. Journal of Comparative Neurology. 2002;454(3):241-254. PMID:12442319
6.remote Y, Kaczmarek LK. Slack, Slick and Slam channels: roles in neuronal excitability, neuroprotection and neurodegeneration. Brain Research. 2020;1732:146738. PMID:32035170
- Rudy B, McBain CJ. Kv3 channels: voltage-gated K+ channels designed for high-frequency repetitive firing. Trends in Neurosciences. 2001;24(9):517-526. PMID:11530637
- Gu N, Vervaeke K, Storm JF. Slack and Slick potassium channels in pyramidal neurons. Neuropharmacology. 2007;52(3):683-688. PMID:17097100